Works matching DE "SEMAGLUTIDE"

Results: 502
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Correction.

    Published in:
    2025
    Publication type:
    Correction Notice
    18

    Evaluating the safety profile of semaglutide: an updated meta-analysis.

    Published in:
    Current Medical Research & Opinion, 2024, v. 40, n. 9, p. 1495, doi. 10.1080/03007995.2024.2383731
    By:
    • Rivera, Frederick Berro;
    • Arias-Aguirre, Eloise;
    • Aguirre, Zedrick;
    • Ybañez, Mc John C.;
    • Rubia, Janos Marc M.;
    • Galang, Danica Janine;
    • Lumbang, Grace Nooriza;
    • Ruyeras, Jade Monica Marie J.;
    • Magalong, John Vincent;
    • Pine, Polyn Luz;
    • Amigo, John Andrew C.;
    • Ansay, Marie Francesca M.;
    • Zelenkov, Nenad;
    • Thomas, Steve Samuel;
    • Vijayaraghavan, Krishnaswami
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Semaglutide and Cardiovascular Outcomes by Baseline HbA<sub>1c</sub> and Change in HbA<sub>1c</sub> in People With Overweight or Obesity but Without Diabetes in SELECT.

    Published in:
    Diabetes Care, 2024, v. 47, n. 8, p. 1360, doi. 10.2337/dc24-0764
    By:
    • Lingvay, Ildiko;
    • Deanfield, John;
    • Kahn, Steven E.;
    • Weeke, Peter E.;
    • Toplak, Hermann;
    • Scirica, Benjamin M.;
    • Rydén, Lars;
    • Rathor, Naveen;
    • Plutzky, Jorge;
    • Morales, Cristobal;
    • Lincoff, A. Michael;
    • Lehrke, Michael;
    • Jeppesen, Ole Kleist;
    • Gajos, Grzegorz;
    • Colhoun, Helen M.;
    • Cariou, Bertrand;
    • Ryan, Donna
    Publication type:
    Article
    29

    Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

    Published in:
    Diabetes Care, 2024, v. 47, n. 8, p. 1350, doi. 10.2337/dc24-0491
    By:
    • Kahn, Steven E.;
    • Deanfield, John E.;
    • Jeppesen, Ole Kleist;
    • Emerson, Scott S.;
    • Boesgaard, Trine Welløv;
    • Colhoun, Helen M.;
    • Kushner, Robert F.;
    • Lingvay, Ildiko;
    • Burguera, Bartolome;
    • Gajos, Grzegorz;
    • Horn, Deborah Bade;
    • Hramiak, Irene M.;
    • Jastreboff, Ania M.;
    • Kokkinos, Alexander;
    • Maeng, Michael;
    • Matos, Ana Laura S.A.;
    • Tinahones, Francisco J.;
    • Lincoff, A. Michael;
    • Ryan, Donna H.
    Publication type:
    Article
    30
    31
    32
    33
    34

    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009
    By:
    • Rossing, Peter;
    • Baeres, Florian M M;
    • Bakris, George;
    • Bosch-Traberg, Heidrun;
    • Gislum, Mette;
    • Gough, Stephen C L;
    • Idorn, Thomas;
    • Lawson, Jack;
    • Mahaffey, Kenneth W;
    • Mann, Johannes F E;
    • Mersebach, Henriette;
    • Perkovic, Vlado;
    • Tuttle, Katherine;
    • Pratley, Richard
    Publication type:
    Article
    35
    36

    Clinical challenge.

    Published in:
    Australian Journal of General Practice, 2025, v. 54, n. 4, p. 208
    Publication type:
    Article
    37
    38

    An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database.

    Published in:
    Biomedicines, 2024, v. 12, n. 5, p. 1124, doi. 10.3390/biomedicines12051124
    By:
    • Butuca, Anca;
    • Dobrea, Carmen Maximiliana;
    • Arseniu, Anca Maria;
    • Frum, Adina;
    • Chis, Adriana Aurelia;
    • Rus, Luca Liviu;
    • Ghibu, Steliana;
    • Juncan, Anca Maria;
    • Muntean, Andrei Catalin;
    • Lazăr, Antonina Evelina;
    • Gligor, Felicia Gabriela;
    • Morgovan, Claudiu;
    • Vonica-Tincu, Andreea Loredana
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.

    Published in:
    Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1240279
    By:
    • García de Lucas, María Dolores;
    • Caballero, Irene;
    • Carlos Fernández-García, José;
    • Domínguez-Rodríguez, Manuel;
    • Moreno-Moreno, Paloma;
    • Jiménez-Millán, Anabel;
    • Botana-López, Manuel;
    • Avilés, Beatriz;
    • Francisco Merino-Torres, Juan;
    • Soto, Alfonso;
    • Tejera, Cristina;
    • Morales, Cristóbal
    Publication type:
    Article
    49
    50